Motivating clinical context Motivating clinical context
Clinical trial on Adenosine deaminase deficiency Very rare disease (1 case/million live birth/year) + Fragile population + Innovative gene therapy a non randomized study a non randomized study is planned to assess the efficacy and safety of gene therapy as treatment for ADA-SCID End End --points: points:
-hazard of death -> One-sample Log-rank test (Breslow 1975) -rate of severe recurrent infections (defined as infections requiring hospitalization) (Lawless and Nadeau, 1995) ) ( ) ( :
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No assumption of independent increments • magnitude of effect (10-30% reduction of the mean number of events at τ );
• censoring mechanisms . 
T (1) T (1)R T (2)R T (3)R T (4)R T (1) T (1)R T (2)R T (3)R T (4)

